Status:
COMPLETED
HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases
Lead Sponsor:
Indiana University
Conditions:
Human Papilloma Virus Vaccine Hesitancy
Eligibility:
All Genders
9-75 years
Brief Summary
For the identified groups of patients (survivors of childhood cancer and youth with sickle cell disease) the investigators want to better understand the barriers to, and facilitators of, HPV vaccinati...
Eligibility Criteria
Inclusion
- Age 9-21 years of age for patients with sickle cell disease or cancer.
- Caregiver of patient with sickle cell disease or cancer.
- Healthcare provider of patient with sickle cell disease or cancer.
Exclusion
- n/a
Key Trial Info
Start Date :
January 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 5 2022
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT04667702
Start Date
January 4 2021
End Date
July 5 2022
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riley Hospital for Children - Indiana University
Indianapolis, Indiana, United States, 46202